Trunk Impairment and Upper Extremity Function
September 8, 2025 updated by: Emre Şenocak, Karadeniz Technical University
CAN TRUNK IMPAIRMENT LEVEL AND UPPER EXTREMITY FUNCTIONAL CAPACITY IN STROKE SURVIVORS IN THE ACUTE PERIOD PREDICT TRUNK RECOVERY IN THE SUBACUTE PERIOD?
This study examines whether early-term upper extremity functions of acute stroke patients can be a tool for predicting later-period trunk functions.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
55
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Istanbul
-
Istanbul, Istanbul, Turkey (Türkiye), 34083
- Bağcılar Training and Research Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Acute Strokers
Description
Inclusion Criteria:
- Patients aged 30-80 years with a confirmed diagnosis of ischemic or hemorrhagic stroke were considered for participation.
Exclusion Criteria:
- Patients with secondary orthopedic and/or neurological conditions, lumbosacral injuries, impaired consciousness, unilateral neglect, recurrent stroke, or a Mini-Mental State Examination score <24 were excluded from the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Acute Strokers
Individuals with early-stage stroke were included in the study.
|
No intervention was applied to the patients within the scope of this study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Trunk Impairment Scale
Time Frame: Baseline
|
Three items of the scale assess static sitting balance, ten assess dynamic sitting balance, and four assess trunk coordination.
The maximum score that can be obtained from these three sections is 23 points.
|
Baseline
|
|
Trunk Impairment Scale
Time Frame: 30 days after Baseilne assessment
|
Three items of the scale assess static sitting balance, ten assess dynamic sitting balance, and four assess trunk coordination.
The maximum score that can be obtained from these three sections is 23 points.
|
30 days after Baseilne assessment
|
|
Wolf Motor Function Test
Time Frame: Baseline
|
The test is a performance tool consisting of seventeen items designed to evaluate the motor skills of the upper extremity.
While fifteen items assess functional skills, two items determine muscle strength.
Muscle strength was not used in this study.
A total score was calculated for the patients' functional skills.
The test is scored between 0-5, and the total score varies between 0-75 points for this study
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 25, 2024
Primary Completion (Actual)
November 25, 2024
Study Completion (Actual)
November 25, 2024
Study Registration Dates
First Submitted
September 8, 2025
First Submitted That Met QC Criteria
September 8, 2025
First Posted (Estimated)
September 15, 2025
Study Record Updates
Last Update Posted (Estimated)
September 15, 2025
Last Update Submitted That Met QC Criteria
September 8, 2025
Last Verified
September 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024/76
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.